Unknown

Dataset Information

0

Magnesium Regulates Endothelial Barrier Functions through TRPM7, MagT1, and S1P1.


ABSTRACT: Mg2+-deficiency is linked to hypertension, Alzheimer's disease, stroke, migraine headaches, cardiovascular diseases, and diabetes, etc., but its exact role in these pathophysiological conditions remains elusive. Mg2+ can regulate vascular functions, yet the mechanistic insight remains ill-defined. Data show that extracellular Mg2+ enters endothelium mainly through the TRPM7 channel and MagT1 transporter. Mg2+ can act as an antagonist to reduce Ca2+ signaling in endothelium. Mg2+ also reduces the intracellular reactive oxygen species (ROS) level and inflammation. In addition, Mg2+-signaling increases endothelial survival and growth, adhesion, and migration. Endothelial barrier integrity is significantly enhanced with Mg2+-treatment through S1P1-Rac1 pathways and barrier-stabilizing mediators including cAMP, FGF1/2, and eNOS. Mg2+ also promotes cytoskeletal reorganization and junction proteins to tighten up the barrier. Moreover, Mg2+-deficiency enhances endothelial barrier permeability in mice, and Mg2+-treatment rescues histamine-induced transient vessel hyper-permeability in vivo. In summary, Mg2+-deficiency can cause deleterious effects in endothelium integrity, and Mg2+-treatment may be effective in the prevention or treatment of vascular dysfunction.

SUBMITTER: Zhu D 

PROVIDER: S-EPMC6755513 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Magnesium Regulates Endothelial Barrier Functions through TRPM7, MagT1, and S1P1.

Zhu Donghui D   You Jing J   Zhao Nan N   Xu Huaxi H  

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 20190730 18


Mg<sup>2+</sup>-deficiency is linked to hypertension, Alzheimer's disease, stroke, migraine headaches, cardiovascular diseases, and diabetes, etc., but its exact role in these pathophysiological conditions remains elusive. Mg<sup>2+</sup> can regulate vascular functions, yet the mechanistic insight remains ill-defined. Data show that extracellular Mg<sup>2+</sup> enters endothelium mainly through the TRPM7 channel and MagT1 transporter. Mg<sup>2+</sup> can act as an antagonist to reduce Ca<sup>2  ...[more]

Similar Datasets

| S-EPMC3163385 | biostudies-literature
| S-EPMC2682440 | biostudies-literature
| S-EPMC7736535 | biostudies-literature
| S-EPMC4728386 | biostudies-other
| S-EPMC6212439 | biostudies-other
| S-EPMC6704462 | biostudies-literature
| S-EPMC3860306 | biostudies-other
| S-EPMC5322162 | biostudies-literature
| S-EPMC2732712 | biostudies-literature
| S-EPMC3234757 | biostudies-literature